SAM #549d9c266b1a435b887f5676c2dbd82d

NCI/FNLCR IDIQ construction-services subcontract, Solicitation H27-1001

NCI is seeking proposals for an IDIQ construction-services subcontract supporting the Frederick National Laboratory for Cancer Research in Maryland. - Opportunity: Solicitation H27-1001 for construction services under the NCI Multiple Award IDIQ Construction Contract. - Agencies and organizations: National Institutes of Health (NIH), National Cancer Institute (NCI), and Frederick National Laboratory for Cancer Research (FNLCR). Leidos Biomedical Research, Inc. operates FNLCR for NCI and is seeking proposals for the subcontract. - Proposal deadline: November 20, 2026, at 3:00 p.m. Eastern Time. - Scope and quantities: The notice identifies IDIQ construction services but does not specify individual projects, tasks, quantities, technical requirements, or a contract value. - Products and OEMs: No products, part numbers, or manufacturers are identified.

Description

SOLCITATION H27-1001 Description of Work: Frederick National Laboratory for Cancer Research (FNLCR) Operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute requires an Indefinite Delivery/Indefinite Quantity Subcontract for construction services for the Frederick National Laboratory for Cancer Research (FNLCR).

To obtain a copy of solicitation H27-1001 and other information concerning this opportunity, please refer to: https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/construction-idiq-contract or contact Matthew Hull (Contracts Manager) at matthew.hull@nih.gov

For information concerning other opportunities with the FNLCR, please refer to: https://frederick.cancer.gov/workwithus/solicitations Background Information: Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick. The effort to be performed will be part of Leidos Biomed’s Prime Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD.

The FNLCR is a Government-Owned Contractor-Operated Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, Government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024 & HHSN261201500003I, which provides Operations and Technical Support (OTS) for the FNLCR. The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this Special Notice as no information is being requested. Please be advised that any submissions provided, despite that no information is requested, become Government property and will not be returned, nor will there be any ensuing discussions or debriefings.

Responses submitted to this Special Notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any.

View original listing